| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $67.0M | +106.9% |
| SG&A Expense | $22.7M | +74.4% |
| Operating Income | -$89.7M | -97.6% |
| Income Tax | $0 | — |
| Net Income | -$73.2M | -73.8% |
| EPS (Basic) | -$2.89 | +67.4% |
| EPS (Diluted) | -$2.89 | +67.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.5M | -78.3% |
| Current Assets | $268.8M | +28.7% |
| Total Assets | $309.0M | +46.9% |
| Current Liabilities | $8.9M | +78.1% |
| Total Liabilities | $8.9M | +70.4% |
| Stockholders' Equity | $300.1M | +46.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.3M | -175.1% |
| Capital Expenditures | $9K | -83.9% |
| Investing Cash Flow | -$194.3M | -5160.0% |
| Financing Cash Flow | $161.3M | +3.0% |
| Free Cash Flow | -$77.3M | -174.6% |